Genetic polymorphisms to evaluate the risk of myocardial infarction: A long way away

Thrombosis and Haemostasis

Volumn 86, Issue 5, 2001, Pages 1136-1138

  Merlini, P A ^a   Ardissino, D ^a  

^a Parma Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HEMOSTATIC AGENT; INTERLEUKIN 1 RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROCOAGULANT; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

AGE; ALLELE; ASSAY; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE MARKER; GENE ACTIVITY; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; NOTE; PHENOTYPE; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOEMBOLISM; GENETICS; HAPLOTYPE;

HAPLOTYPES; HUMAN; MYOCARDIAL INFARCTION; POLYMORPHISM (GENETICS); RISK FACTORS;

EID: 0035164246     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615979     Document Type: Note

References (32)

1. Hemostatic risk factors for atherothrombotic disease
2. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: The ECTIM study
3. Gender-specific associations of the fibrinogen Bβ 448 polymorphism, fibrinogen levels, and acute coronary disease
4. A common mutatÌon (G-455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on The Copenhagen City Heart Study
5. Positive association of the β-fibrinogen H1/H2 gene variation to basal fibrinogen levels and to increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction
6. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction
7. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype
8. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and France but is not a strong indicator of MI risk in the ECTIM study
9. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men
10. Arg506GIn factor V mutation in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction
11. Evidence against heterozygous coagulation factor V 1691 GA mutation for coronary artery disease and myocardial infarction
12. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: Results from the Cardiovascular Health Study
13. Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease
14. The factor II G20210A and factor VG1691A gene transitions and coronary heart disease
15. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
16. Premature ischaemic heart disease and the gene for coagulation factor V
17. Prothrombotic genetic risk factors in young survivors of myocardial infarction
18. The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease
19. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
20. Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A
21. The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease
22. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
23. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease
24. The prothrombin 20210A allele and its association with myocardial infarction
25. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men
26. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
27. Glycoprotein IIIa P1A polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly
28. Association of the platelet P1 A polymorphism of glycoprotein IIb/IIIa and the fibrinogen β448 polymorphism with myocardial infarction and extent of coronary artery disease
29. Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen Ib (HPA-1b/PI A2) is an inherited risk factor for premature myocardial infarction in coronary artery disease
30. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients
31. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
32. A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction